Palliative Care for the Cancer Patient

Primary Care - Clinics in Office Practice

Volumn 36, Issue 4, 2009, Pages 781-810

  Reville, Barbara ^a   Axelrod, David ^a   Maury, Rebecca ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Anorexia; Cancer related fatigue; Constipation; Dyspnea; Nausea; Pain; Palliative care; Vomiting

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CELECOXIB; CLONAZEPAM; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; DULOXETINE; GABAPENTIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; INDOMETACIN; KETOROLAC; MELOXICAM; MORPHINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PREDNISONE; PROTON PUMP INHIBITOR; RADIOISOTOPE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

BONE PAIN; CANCER DIAGNOSIS; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG MEGADOSE; HUMAN; NEUROPATHIC PAIN; PATIENT ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STANDARD; SYMPTOM;

CONSTIPATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; MEDICAL ONCOLOGY; NAUSEA; NEOPLASMS; PAIN; PALLIATIVE CARE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PRIMARY HEALTH CARE; UNITED STATES; VOMITING;

EID: 71549156878     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2009.07.010     Document Type: Review

References (146)

1. Melvin T.A. The primary care physician and palliative care. Prim Care 28 (2001) 1-4
2. Dalal S., Del Fabbro E., and Bruera E. Symptom control in palliative care - part I: oncology as a paradigmatic example. J Palliat Med 9 (2006) 391-407
3. Sepúlveda C., Marlin A., Yoshida T., et al. Palliative care: the World Health Organization's global perspective. J Pain Symptom Manage 24 (2002) 91-96
4. Tremblay A., and Breitbart W. Psychiatric dimensions of palliative care. Neurol Clin 19 (2001) 949-967
5. National Consensus Project for Quality Palliative Care. Clinical practice guidelines for quality palliative care. 2nd edition. Pittsburgh (PA): 2004. p. 1-66. Available at: http://www.nationalconsensusproject.org (2004)
6. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Palliative care. Available at:. http://www.nccn.org/professionals/physician_gls/PDF/palliative.pdf Accessed November 22, 2008
7. Too much treatment? aggressive medical care can lead to more pain, with no gain. Consum Rep (2008) 40-44
8. Morgan L. New analysis shows hospitals continue to implement palliative care programs at rapid pace. Available at:. www.capc.org Accessed April 14, 2008
9. U.S. News & World Reports. Palliative care programs could boost hospitals bottom line. Available at:. http://health.usnews.com/articles/health/healthday/2008/09/12/palliative-care-programs-could-boost-hospitals.html Accessed September 12, 2008
10. In: Mersky H., and Bogduk N. (Eds). Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd edition (1994), IASP Press, Seattle (WA)
11. American Pain Society. Principles of analgesic use in the treatment of acute pain; and cancer pain. 4th edition (1999), American Pain Society, Glenview (IL)
12. Kris A.E., and Dodd M.J. Symptom experience of adult hospitalized medical-surgical patients. J Pain Symptom Manage 28 (2004) 451-459
13. Germino B.B. Symptom distress and quality of life. Semin Oncol Nurs 3 (1987) 299-302
14. Kroenke K., Stump T., Clark D.O., et al. Symptoms in hospitalized patients: outcome and satisfaction with care. Am J Med 107 (1999) 425-431
15. Abraham A., Kutner J.S., and Beaty B. Suffering at the end of life in the setting of low physical symptom distress. J Palliat Med 9 (2006) 658-665
16. Dix P., Sandhar B., Murdoch J., et al. Pain on medical wards in a district general hospital. Br J Anaesth 92 (2004) 235-237
17. Portenoy R.K., Thaler H.T., Kornblith A.B., et al. Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3 (1994) 183
18. Cleeland C.S., Gonin R., Hatfield A.K., et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330 (1994) 592-596
19. Oliver J.W., Kravitz R.L., Kaplan S.H., et al. Individualized patient education and coaching to improve pain control among cancer outpatients. J Clin Oncol 19 (2001) 2206-2212
20. Noble B., Clark D., Meldrum M., et al. The measurement of pain, 1945-2000. J Pain Symptom Manage 29 (2005) 14-21
21. Ripamonti C., and Bandieri E. Pain therapy. Crit Rev Oncol Hematol 70 (2009) 145-159
22. Robb K., and Oxberry S. A Cochrane systematic review of transcutaneous electrical nerve stimulation for cancer pain. J Pain Symptom Manage 37 (2009) 746-753
23. Vecht C.J., Haaxma-Reiche H., van Putten W.L., et al. Initial bolus of conventional versus high-dose dexamethasone metastatic spinal cord compression. Neurology 39 (1989) 1255-1257
24. Wong D.L., Hockenberry-Eaton M., Wilson D., et al. Wong's essentials of pediatric nursing. 6th edition (2001), Mosby, St. Louis (MO)
25. Herr K., Bjoro K., and Decker S. Tools for assessment of pain in nonverbal older adults with dementia: a state-of-the-science review. J Pain Symptom Manage 31 (2006) 170-192
26. Ardery G., Herr K.A., Titler M.G., et al. Assessing and managing acute pain in older adults: a research base to guide practice. Medsurg Nurs 12 (2003) 7-18 quiz 19
27. de Leon-Casasola O.A. Current developments in opioid therapy for management of cancer pain. Clin J Pain 24 Suppl 10 (2008) S3-S7
28. Woolf C.J., American college of physicians, and American Physiological Society. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 140 (2004) 441-451
29. Chong M.S., and Bajwa Z.H. Diagnosis and treatment of neuropathic pain. J Pain Symptom Manage 25 (2003) S4-S11
30. Jensen T.S., Gottrup H., Sindrup S.H., et al. The clinical picture of neuropathic pain. Eur J Pharmacol 429 (2001) 1-11
31. Chen H., Lamer T.J., Rho R.H., et al. Contemporary management of neuropathic pain for the primary care physician. Mayo Clin Proc 79 (2004) 1533-1545
32. Jadad A.R., and Browman G.P. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. JAMA 274 (1995) 1870-1873
33. Grond S., Zech D., Schug S.A., et al. Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage 6 (1991) 411-422
34. Orza F., Boswell M.V., and Rosenberg S.K. Neuropathic pain: review of mechanisms and pharmacologic management. NeuroRehabilitation 14 (2000) 15-23
35. Sindrup S.H., and Jensen T.S. Pharmacologic treatment of pain in polyneuropathy. Neurology 55 (2000) 915-920
36. Watson C.P. Antidepressant drugs as adjuvant analgesics. J Pain Symptom Manage 9 (1994) 392-405
37. Rowbotham M.C., Goli V., Kunz N.R., et al. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 110 (2004) 697-706
38. Reddy S., and Patt R.B. The benzodiazepines as adjuvant analgesics. J Pain Symptom Manage 9 (1994) 510-514
39. Hugel H., Ellershaw J.E., and Dickman A. Clonazepam as an adjuvant analgesic in patients with cancer-related neuropathic pain. J Pain Symptom Manage 26 (2003) 1073-1074
40. Jatoi A., Kumar S., Sloan J.A., et al. On appetite and its loss. J Clin Oncol 21 (2003) 79-81
41. Eisenberg E., McNicol E.D., and Carr D.B. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA 293 (2005) 3043-3052
42. Kalso E., Edwards J.E., Moore R.A., et al. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 112 (2004) 372-380
43. Inturrisi C.E. Clinical pharmacology of opioids for pain. Clin J Pain 18 (2002) S3-13
44. McQuay H. Opioids in pain management. Lancet 353 (1999) 2229-2232
45. Fohr S.A. The double effect of pain medication: separating myth from reality. J Palliat Med 1 (1998) 315-328
46. Murray A., and Hagen N.A. Hydromorphone. J Pain Symptom Manage 29 (2005) S57-S66
47. Kalso E. Oxycodone. J Pain Symptom Manage 29 (2005) S47-S56
48. Dalton J.A., and Youngblood R. Clinical application of the World Health Organization analgesic ladder. J Intraven Nurs 23 (2000) 118-124
49. Porter J., and Jick H. Addiction rare in patients treated with narcotics. N Engl J Med 302 (1980) 123
50. Hojsted J., and Sjogren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 11 (2007) 490-518
51. Savage S.R. Addiction in the treatment of pain: significance, recognition, and management. J Pain Symptom Manage 8 (1993) 265-278
52. Gammaitoni A.R., Fine P., Alvarez N., et al. Clinical application of opioid equianalgesic data. Clin J Pain 19 (2003) 286-297
53. de Stoutz N.D., Bruera E., and Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 10 (1995) 378-384
54. Foley K.M., and Houde R.W. Methadone in cancer pain management: individualize dose and titrate to effect. J Clin Oncol 16 (1998) 3213-3215
55. William L., and Macleod R. Management of breakthrough pain in patients with cancer. Drugs 68 (2008) 913-924
56. Svendsen K.B., Andersen S., Arnason S., et al. Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms. Eur J Pain 9 (2005) 195-206
57. Angst M.S., and Clark J.D. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 104 (2006) 570-587
58. Axelrod D.J., and Reville B. Using methadone to treat opioid-induced hyperalgesia and refractory pain. J Opioid Manag 3 (2007) 113-114
59. Etches R.C. Patient-controlled analgesia. Surg Clin North Am 79 (1999) 297-312
60. Walder B., Schafer M., Henzi I., et al. Efficacy and safety of patient-controlled opioid analgesia for acute postoperative pain. A quantitative systematic review. Acta Anaesthesiol Scand 45 (2001) 795-804
61. Viscusi E.R., Reynolds L., Chung F., et al. Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial. JAMA 291 (2004) 1333-1341
62. Hans G., and Robert D.N. Treatment of an acute severe central neuropathic pain syndrome by topical application of lidocaine 5% patch: a case report. Spinal Cord 46 (2008) 311-313
63. Joshi G.P. Multimodal analgesia techniques for ambulatory surgery. Int Anesthesiol Clin 43 (2005) 197-204
64. Oncel M., Sencan S., Yildiz H., et al. Transcutaneous electrical nerve stimulation for pain management in patients with uncomplicated minor rib fractures. Eur J Cardiothorac Surg 22 (2002) 13-17
65. Kutner J.S., Smith M.C., Corbin L., et al. Massage therapy versus simple touch to improve pain and mood in patients with advanced cancer: a randomized trial. Ann Intern Med 149 (2008) 369-379
66. Glover J., Dibble S.L., Dodd M.J., et al. Mood states of oncology outpatients: does pain make a difference?. J Pain Symptom Manage 10 (1995) 120-128
67. Barsevick A.M. The elusive concept of the symptom cluster. Oncol Nurs Forum 34 (2007) 971-980
68. Arseven A., Chang C., Arseven O.K., et al. Assessment instruments. Clin Geriatr Med 21 (2005) 121-146
69. Ingham J.M., and Portenoy R.K. The measurement of pain and other symptoms. In: Doyle D., Hanks G.W.C., Cherny N., et al. (Eds). Oxford textbook of palliative medicine. 3rd edition (2005), Oxford University Press Inc, New York 167-180
70. Del Fabbro E., Dalal S., and Bruera E. Symptom control in palliative care - part II: cachexia/anorexia and fatigue. J Palliat Med 9 (2006) 409-436
71. Lyons K.D., Bakitas M., Hegel M.T., et al. Reliability and validity of the functional assessment of chronic illness therapy-palliative care (FACIT-pal) scale. J Pain Symptom Manage 37 (2009) 23-32
72. Chang V.T., Hwang S.S., Kasimis B., et al. Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMAS). Cancer Invest 22 (2004) 526-536
73. Chang V.T., Hwang S.S., Feuerman M., et al. The Memorial Symptom Assessment Scale Short Form (MSAS-SF). Cancer Invest 89 (2000) 1162-1171
74. Chang V.T., Hwang S.S., and Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer Invest 88 (2000) 2164-2171
75. Felce D., and Perry J. Quality of life: its definition and measurement. Res Dev Disabil 16 (1995) 51-74
76. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Distress management. Available at: http://www.nccn.org/professionals/physician_glst/PDF/distress.pdf/pages1-27. Accessed September 24, 2009.
77. Glare P. Clinical predictors of survival in advanced cancer. J Support Oncol 3 (2005) 331-341
78. Karnofsky D.A. Determining the extent of the cancer and clinical planning for cure. Cancer 22 (1968) 730-734
79. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
80. Anderson F., Downing G.M., Hill J., et al. Palliative Performance Scale (PPS): a new tool. J Palliat Med 12 (1996) 5-11
81. Longstreth G.F., Thompson W.G., Chey W.D., et al. Functional bowel disorders. Gastroenterology 130 (2006) 1480-1491
82. National Cancer Institute. Constipation. Available at:. http://www.cancer.gov/cancertopics/pdq/supportivecare/gastrointestinalcomplications/HealthProfessional/page3 Accessed September 11, 2008
83. McMillan S.C. Pain and symptom management. Presence and severity of constipation in hospice patients with advanced cancer. Am J Hosp Palliat Med 19 (2002) 426-430
84. Solomon R., and Cherny N.I. Constipation and diarrhea in patients with cancer. Cancer J 12 (2006) 355-364
85. Carver A.C., and Foley K.M. Symptom assessment and management. Neurol Clin 19 (2001)
86. McNicol E.D., Boyce D., Schumann R., et al. Mu-opioid antagonists for opioid-induced bowel dysfunction. Cochrane Database Syst Rev (2008) 2:CD006332
87. Woolery M., Bisanz A., Lyons H.F., et al. Putting evidence into practice: evidence-based interventions for the prevention and management of constipation in patients with cancer. Clin J Oncol Nurs 12 (2008) 317-337
88. Smith L.C., Bertolotti P., Curran K., et al. The IMF Leadership Board. Gastrointestinal side effects associated with novel therapies in patients with multiple myeloma. Clin J Oncol Nurs 12 Suppl (2008) 37-45
89. Brodie K. Constipation. In: Preston F.A., and Cunningham R.S. (Eds). Clinical guidelines for symptom management in oncology (1998), Clinical Insights Press, New York 26-32
90. Miles C.L., Fellowes D., Goodman M.L., et al. Laxatives for the management of constipation in palliative care patients. Cochrane Database Syst Rev (2008) 3
91. Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev (2008) 3
92. Sykes N.P. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer. Palliat Med 10 (1996) 135-144
93. Thomas J., Karver S., Cooney G.A., et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 358 (2008) 2332-2343
94. Mitchell S.A., Beck S.L., Hood L.E., et al. Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment. Clin J Oncol Nurs 11 (2007) 99-113
95. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. cancer-related fatigue. Available at:. http://www.nccn.org/professionals/physician_gls/PDF/fatigue.pdf Accessed September 11, 2008
96. Breitbart W., and Alici-Evcimen Y. Update on psychotropic medications for cancer-related fatigue. J Natl Compr Canc Netw 5 (2007) 1081-1091
97. Butt Z., Rosenbloom S.K., Abernethy A.P., et al. Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. J Natl Compr Canc Netw 6 (2008) 448-455
98. Cella D., Paul D., Yount S., et al. What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN). Cancer Invest 21 (2003) 526-535
99. Stricker C.T., Drake D., Hoyer K.A., et al. Evidence-based practice for fatigue management in adults with cancer: exercise as an intervention. Oncol Nurs Forum 31 (2004) 963-974
100. Braun I.M., Greenberg D.B., and Pirl W.F. Evidence-based report on the occurrence of fatigue in long-term cancer survivors. J Natl Compr Canc Netw 6 (2008) 347-354
101. Mendoza T.R., Wang X.S., Cleeland C.S., et al. The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 85 (1999) 1186-1196
102. Piper B.F., Borneman T., Sun V.C., et al. Cancer-related fatigue: role of oncology nurses in translating national comprehensive cancer network assessment guidelines into practice. Clin J Oncol Nurs 12 Suppl (2008) 37-47
103. Luctkar-Flude M.F., Groll D.L., Tranmer J.E., et al. Fatigue and physical activity in older adults with cancer: a systematic review of the literature. Cancer Nurs 30 (2007) E35-E45
104. Markes M., Brockow T., and Resch K.L. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev 2 (2008)
105. Kvale P.A., Simoff M., and Prakash U. Diagnosis and management of lung cancer: ACCP evidence-based guidelines: lung cancer guidelines. Chest 123 (2003) 284
106. Dudgeon D.J., and Rosenthal S. Management of dyspnea and cough in patients with cancer. Hematol Oncol Clin North Am 10 (1996) 157
107. Reuben D.B., and Mor V. Dyspnea in terminally ill cancer patients. Chest 89 (1986) 234
108. Luce J.M., and Luce J.A. Perspectives on care at the close of life: management of dyspnea in patients with far-advanced lung disease: "once I lose it, it's kind of hard to catch it...". JAMA 285 (2001) 1331
109. Mazzocato C., Buclin T., and Raphin C.H. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double blind controlled trial. Ann Oncol 10 (1999) 1511
110. Bruera E., Macmillan K., Pither J., et al. Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage 5 (1990) 341
111. Zeppetella G. The palliation of dyspnea in terminal disease. Am J Hosp Palliat Care 15 (1998) 322
112. Cowcher K., and Hanks G. Long-term management of respiratory symptoms in advanced cancer. J Pain Symptom Manage 5 (1990) 320
113. Bruera E., de Stoutz N., Velasco-Leiva A., et al. The effects of oxygen on the intensity of dyspnea in hypoxic terminal cancer patients. Lancet 342 (1993) 13
114. Bruera E., Scholler T., and MacEachern T. Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of the N of 1 randomized controlled trial. J Pain Symptom Manage 7 (1992) 365
115. Dudley D.L., Glaser E.M., and Jorgenson B.N. Psychosocial concomitants to rehabilitation in chronic obstructive pulmonary disease, part II. Chest 77 (1980) 544
116. Davis M., and Walsh D. Treatment of nausea and vomiting in advanced cancer. Support Care Cancer 8 (2000) 444
117. Reuben D.B., and Mor V. Nausea and vomiting in terminal cancer patients. Arch Intern Med 146 (1986) 2021
118. Twycross R.G., and Lack S.A. Nausea and vomiting in advanced cancer. Eur J Palliat Care 5 (1998) 39
119. Rousseau P. Antiemetic therapy in adults with terminal disease: a brief review. Am J Hosp Palliat Care 12 (1995) 13-18
120. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Antiemesis. Available at:. http://www.nccn.org/professionals/physician_gls/PDF/antiemesis.pdf Accessed October 2, 2008
121. Lichter I. Results of anti-emetic management in terminal illness. J Palliat Care 9 (1993) 19
122. Bentley A., and Boyd K. Use of clinical pictures in the management of nausea and vomiting: a prospective audit. Palliat Med 15 (2001) 247
123. Glare P., Pereira G., Kristjanson L.J., et al. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer 12 (2004) 432-440
124. Lichter I. Which anti-emetic?. J Palliat Care 9 (1993) 42
125. Mystakidou K., Befon S., and Liossi C. Comparison of tropisetron and chlorpromazine combinations in the control of nausea and vomiting in patients with advanced cancer. J Pain Symptom Manage 15 (1998) 176
126. Bruera E., Belzile M., and Neumann C. A double blind crossover study of controlled release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage 19 (2000) 427
127. Bruera E., Seifert L., and Wantanabe S. Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen. J Pain Symptom Manage 11 (1996) 147
128. Critchley P., Plach N., Grantham M., et al. Efficacy of haloperidol in the treatment of nausea and vomiting in the palliative patient: a systematic review. J Pain Symptom Manage 22 (2001) 631-634
129. American Society of Health-Systems Pharmacists. Therapeutic guidelines on the pharmacological management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. Am J Health Syst Pharm 56 (1999) 729
130. Pereira J., and Bruera E. Successful management of intractable nausea with ondansetron: a case study. J Palliat Care 12 (1996) 47
131. Craig J.B., and Powell B.L. Review: the management of nausea and vomiting in clinical oncology. Am J Med Sci 293 (1987) 34
132. Lucas V.S., and Lazlo J. Delta-9 tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy. JAMA 243 (1980) 1241
133. Beal J.E., Olson R., and Laubenstein L. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 10 (1995) 89
134. Laval G., Girardier J., Lassauniére J.M., et al. The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove obstruction?. Palliat Med 14 (2000) 3-10
135. Pugh R. The management of nausea and vomiting in patients with terminal cancer. CME. J Geriatr Med 3 (2001) 110
136. Robostelli Della Cuna C., Pellegrini A., and Piazzi M. Effect of methyl-prednisolone sodium succinate on quality of life in pre-terminal cancer patients: a placebo controlled multi-centre study. Eur J Cancer 25 (1989) 1817
137. Lichter I. Nausea and vomiting in patients with cancer. Hematol Oncol Clin North Am 10 (1996) 207-220
138. Peteet J.R., Medeiros C., Slavin L., et al. Psychological aspects of artificial feeding in cancer patients. JPEN J Parenter Enteral Nutr 5 (1981) 138-140
139. Bruera E. Clinical management of cachexia and anorexia in patients with advanced cancer. Oncology 49 (1992) 35
140. Loprinzi C.L., Ellison N.M., Schaid D.J., et al. Controlled trial of megestrol acetate for the treatment of cancer, anorexia and cachexia. J Natl Cancer Inst 82 (1990) 1127
141. Moertel C., Schutt A.G., and Reiteneier R.J. Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer 33 (1974) 1607
142. Willcox J.C., Corr J., Shaw K., et al. Prednisolone as an appetite stimulant in patients with cancer. Br Med J (Clin Res Ed) 27 (1984) 288
143. Anonymous. Parenteral nutrition in patients receiving cancer chemotherapy. Ann Intern Med 110 (1989) 734
144. Weisdorf S.A., Lysne J., and Wind D. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation 43 (1987) 833
145. Daly J.M., Hearne B., and Dunaj J. Nutritional rehabilitation in patients with advanced head and neck cancer receiving radiation therapy. Am J Surg 148 (1984) 514
146. Ovesen L., Allingstrup L., and Hannibal J. Effect of dietary counseling on food intake, body weight response rate, survival and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 11 (1993) 2043